Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alkermes, Inc.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has completed the 4-week treatment period (all visits up to and including end of treatment visit) in the antecedent study ALK3831-A305 within 7 days.
Agrees to use an acceptable method of contraception for the duration of the study.
Additional criteria may apply.
You may not be if
Subject is currently taking medications that are contraindicated with olanzapine use.
Subject has a positive test for drugs of abuse at study entry.
Subject is pregnant, planning to become pregnant, or breastfeeding during the study.
